Nichi-Iko
®
Serialization/Track and Trace
Investors
Careers
Anti-Capital Punishment Statement
Contact Us
sagentbiosimilars.com
zoledronicpremix.com
glydo.com
Sagent Pharmaceuticals
Sagent Pharmaceuticals
Home
About
Our Executive Team
Who We Are
What We Do
Why We Do It
Products
PreventIV Measures
®
Home
>
LEVETIRACETAM Injection, USP Recall Information
Sagent
1.
LEVETIRACETAM Injection, USP Recall Information
2.
PHENYLEPHRINE HCl Injection, USP Recall Information
3.
We’re thrilled to keep in touch
4.
Anti-Capital Punishment Statement
5.
Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for $21.75 Per Share in All Cash Transaction
6.
OXACILLIN for Injection, USP Recall Information
7.
OXACILLIN for Injection, USP Recall Information
8.
FLUCONAZOLE Injection, USP in 0.9% Sodium Chloride Recall Information
Total 8 result(s) found. Search for [
] with
Google